Article Versions Notes

George KM, Frantz M-C, Bravo-Altamirano K, LaValle CR, Tandon M, Leimgruber S, Sharlow ER, Lazo JS, Wang QJ, Wipf P. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics. 2011; 3(2):186-228. https://doi.org/10.3390/pharmaceutics3020186

George, Kara M., Marie-Céline Frantz, Karla Bravo-Altamirano, Courtney R. LaValle, Manuj Tandon, Stephanie Leimgruber, Elizabeth R. Sharlow, John S. Lazo, Q. Jane Wang, and Peter Wipf. 2011. "Design, Synthesis, and Biological Evaluation of PKD Inhibitors" Pharmaceutics 3, no. 2: 186-228. https://doi.org/10.3390/pharmaceutics3020186

George, K. M., Frantz, M.-C., Bravo-Altamirano, K., LaValle, C. R., Tandon, M., Leimgruber, S., Sharlow, E. R., Lazo, J. S., Wang, Q. J., & Wipf, P. (2011). Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics, 3(2), 186-228. https://doi.org/10.3390/pharmaceutics3020186